Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multicompartment Models: Overview01:14

Multicompartment Models: Overview

697
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
697
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

65
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
65
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

310
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

449
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
449

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Suprachoroidal Delivery of Anti-Angiogenic Peptide Microparticles Enables Sustained Activity with Favorable Ocular Safety.

bioRxiv : the preprint server for biology·2026
Same author

Structured Schemas for Provenance-Rich, LLM-Assisted QSP Model Calibration.

bioRxiv : the preprint server for biology·2026
Same author

Prioritizing Discovery and Advancements in Arrhythmia Therapies: NIH/NHLBI Workshop.

JACC. Clinical electrophysiology·2026
Same author

A mechanistic computational model of the HIF signaling pathway in endothelial cells.

iScience·2026
Same author

A hERG Blocker Facilitates K<sup>+</sup> Channel Current by Agonizing Pore Opening while Blocking.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Mar 25, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K

Multiscale Modeling in the Clinic: Drug Design and Development.

Colleen E Clancy1, Gary An2, William R Cannon3

  • 1Department of Pharmacology, University of California, Davis, CA, USA. ceclancy@ucdavis.edu.

Annals of Biomedical Engineering
|February 18, 2016
PubMed
Summary

Multiscale computational modeling bridges different scales in pharmacology, advancing drug development and delivery. These validated in silico models offer testable predictions for pharmaceutical research and clinical applications.

Keywords:
Drug deliveryMathematicalMultiscale modelingPharmacologySimulation

More Related Videos

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.5K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.0K

Related Experiment Videos

Last Updated: Mar 25, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.5K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.0K

Area of Science:

  • Pharmacology and Pharmaceutical Sciences
  • Computational Biology and Bioinformatics
  • Biomedical Engineering

Background:

  • Pharmacology involves diverse length and time scales crucial for drug development, design, and delivery.
  • Multiscale computational modeling and simulation are vital for linking phenomena across these scales.
  • In silico approaches offer unique opportunities to bridge laboratory research with clinical applications.

Purpose of the Study:

  • To review the goals, methods, and opportunities of multiscale modeling in drug design and development.
  • To demonstrate the impact of multiscale modeling across various pharmaceutical research areas.
  • To highlight common mathematical and computational techniques used in pharmacometric and systems pharmacology.

Main Methods:

  • Review of multiscale modeling approaches in pharmacometrics and systems pharmacology.
  • Description of mathematical and computational techniques for linking multiple scales.
  • Presentation of state-of-the-art model examples across diverse applications.

Main Results:

  • Multiscale modeling reveals phenomena inaccessible to experimentation, guiding drug design and delivery.
  • Examples showcase applications in cardiac disease, stem cell biology, nanoparticle delivery (cancer therapy, angiogenesis), host-pathogen interactions (metabolic disorders, inflammation, sepsis), and nanomedical systems design.
  • Validated models provide testable predictions for pharmaceutical innovation.

Conclusions:

  • Multiscale modeling is essential for advancing drug development, design, and delivery.
  • Significant opportunities exist for in silico approaches to impact pharmaceutical research and clinical translation.
  • Barriers to the successful clinical translation of these advanced models require focused attention.